rsv

Documents about rsv

• Real-world evidence on RSV vaccine uptake, effectiveness, and safety in older adults: a systematic review and meta-analysis#5394Europe PMC
• Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in Adults#180215ClinicalTrials.gov
• Real-World Effectiveness of Perinatal RSV Immunoprophylaxis#854577ClinicalTrials.gov
• Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f)#234474ClinicalTrials.gov
• Evaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 and RSV 6120/F1/G2/∆NS1, in RSV-Seropositive Children and RSV-Seronegative Infants and Children#896160ClinicalTrials.gov
• Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination#180213ClinicalTrials.gov
• Systems Biological Analysis of Immune Responses to RSV Vaccine#860262ClinicalTrials.gov
• Effect of Heliox on RSV Bronchiolitis#909282ClinicalTrials.gov
• Evaluating the Infectivity, Safety, and Immunogenicity of a Respiratory Syncytial Virus Vaccine (RSV 6120/∆NS2/1030s) in RSV-Seropositive Children and RSV-Seronegative Infants and Children#851118ClinicalTrials.gov
• RESCEU Study, Defining the Burden of Disease of RSV in Older Adults#826040ClinicalTrials.gov
• Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine#154737ClinicalTrials.gov
• Immunogenicity of RSV Vaccines in Residents of Long-Term Care Facilities (LTCF)#195376ClinicalTrials.gov
• Safety and Immunogenicity Study of SCB-1019T in Children#827514ClinicalTrials.gov
• Observational Program to Assess Respiratory Syncytial Virus (RSV) Hospitalization Rate in Population of Children at High-risk of Serious RSV Illness Who Received Palivizumab Immunoprophylaxis#917876ClinicalTrials.gov
• A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants#125948ClinicalTrials.gov
• Impact of the Covid-19 on Respiratory Syncytial Virus (RSV) Epidemic#895247ClinicalTrials.gov
• Anti-RSV Study in Chinese Patients (ASCENT)#900475ClinicalTrials.gov
• BEYFORTUS™ (Nirsevimab) Effectiveness Against Medically-Attended RSV Events in Infants (BEAR Study)#917025ClinicalTrials.gov
• A Study to Evaluate a Single Intramuscular Dose of Motavizumab to Treat Children With Respiratory Syncytial Virus (RSV) Illness#805555ClinicalTrials.gov
• A Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' RSV Investigational Vaccine (ChAd155-RSV) (GSK3389245A) in Healthy Adults#864729ClinicalTrials.gov
• A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge Model#981283ClinicalTrials.gov
• A Study to Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of Age#895750ClinicalTrials.gov
• Public surveillance early warning for older-adult influenza/RSV hospitalization burden#11940DataCite
• A Study of ALS-008176 in Infants Hospitalized With RSV#857350ClinicalTrials.gov
• Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control#981914ClinicalTrials.gov
• ayakamon/BR-RSV-MV#257891LSHTM Data Compass
• fkrauer/RSV-VACC-DE#284678LSHTM Data Compass
• Older-Adult Influenza/RSV Hospital Burden Early Warning (Public Data)#11915DataCite
• Older-Adult Influenza/RSV Hospital Burden Early Warning (Public Data)#11924DataCite
• Older-Adult Influenza/RSV Hospital Burden Early Warning (Public Data)#11939DataCite
• Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) Disease#811039ClinicalTrials.gov
• Adult RSV Vaccination: What Is the Role of RSV Subgroup in Disease Prevention?#237341Springer Nature OA
• Innate Immunity and Respiratory Syncytial Virus (RSV) Infection in Children#881446ClinicalTrials.gov
• An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm Infants#881591ClinicalTrials.gov
• Household Study of COVID-19, Influenza and RSV Burden, Transmission Dynamics and Viral Interaction in South Africa#993126ClinicalTrials.gov
• Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and Above#256948ClinicalTrials.gov
• A Safety and Immunogenicity Trial of a Respiratory Syncytial Virus Vaccine, LYB005 in Healthy Adults#261334ClinicalTrials.gov
• Mutations prevalent in fusion protein signal peptides from African RSV strains#477919WIReDSpace
• RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults#808012ClinicalTrials.gov
• Intermittent Use of Aerosolized Ribavirin for Treatment of RSV#860775ClinicalTrials.gov
• Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France#893691ClinicalTrials.gov
• The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related Hospitalisations in the Australian Capital Territory#830625ClinicalTrials.gov
• RSV table#784723Figshare
• Safety, Tolerability and Immunogenicity of a Maternal Respiratory Syncytial Virus (RSV) Vaccine (MKK900) in Healthy Adult Women#806879ClinicalTrials.gov
• A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults#811932ClinicalTrials.gov
• FINDER® Instrument and FINDER® FLU A/B, RSV, SARS-CoV-2 Test Clinical Evaluation Protocol#855731ClinicalTrials.gov
• Safety and Efficacy Study of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV)#877103ClinicalTrials.gov
• Inno4Vac workshop report part 2: RSV‐controlled human infection model (CHIM) strain selection and immune assays for RSV CHIM studies, November 2021, MHRA, UK#316778Spiral
• Intranasal Delivery of an RSV A2-Derived Pre-F VLP Vaccine Induces Robust Mucosal and Systemic Immunity Against RSV B Strain Without Enhanced Disease.#345243NCBI PubMed Central
• A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.FA2 Followed by Ad35.RSV.FA2 in Healthy Adult Volunteers#426634ClinicalTrials.gov